Trial Profile
An open label, Prospective,Observational study to evaluate the factors associated with discontinuation of Aripiprazole in patients with Schizophrenia after switching from other antipsychotics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2016
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 07 Nov 2016 New trial record